Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis-Reference-Cited by-同舟云学术

Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis

Published:2018-10 Issue:43 Volume:36 Page:6433-6441
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Toepp Angela,Larson Mandy,Wilson Geneva,Grinnage-Pulley Tara,Bennett Carolyne,Leal-Lima Adam,Anderson Bryan,Parrish Molly,Anderson Michael,Fowler Hailie,Hinman Jessica,Kontowicz Eric,Jefferies Jane,Beeman Marvin,Buch Jesse,Saucier Jill,Tyrrell Phyllis,Gharpure Radhika,Cotter Caitlin,Petersen Christine

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. Development of Leishmania vaccines in the era of visceral leishmaniasis elimination;Engwerda;Trans R Soc Trop Med Hyg,2015

2. Novel areas for prevention and control of canine leishmaniosis;Miro;Trends Parasitol,2017

3. Immunotherapeutic approaches to treatment of fungal diseases;Armstrong-James;Lancet Infect Dis,2017

4. Clinical evaluation of terap c vaccine in combined treatment with interferon and ribavirin in patients with hepatitis C;Zaily;Curr Therap Res, Clin Experiment,2017

5. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS ONE,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLGA nanoparticle-delivered Leishmania antigen and TLR agonists as a therapeutic vaccine against cutaneous leishmaniasis in BALB/c mice;International Immunopharmacology;2024-09

2. Combining Killed Vaccine Candidate with Different Adjuvants to Determine Prophylactic Potential against Leishmaniasis;Acta Parasitologica;2024-08-20

3. A panel of recombinant Leishmania donovani cell surface and secreted proteins identifies LdBPK_323600.1 as a serological marker of symptomatic infection;mBio;2024-05-08

4. New Approaches to the Prevention of Visceral Leishmaniasis: A Review of Recent Patents of Potential Candidates for a Chimeric Protein Vaccine;Vaccines;2024-03-05

5. LaSap vaccine: Immunotherapy and immunochemotherapy associated with allopurinol in dogs naturally infected with Leishmania infantum;Parasite Immunology;2024-02